Looking forward to having Emily (Murphy) Yates present at the R/Pharma Conference later in October! The event is free and taking place on Zoom. Learn more and sign up here: https://shorturl.at/T7gMw
Formation Bio
Biotechnology
New York, NY 28,529 followers
Bringing new treatments to patients faster and more efficiently.
About us
Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.
- Website
-
https://www.formation.bio/
External link for Formation Bio
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2013
Locations
-
Primary
16 E 34th Street
Fl 10
New York, NY 10016, US
Employees at Formation Bio
Updates
-
We're honored to be selected as one of the Endpoints News 11 most promising biopharma companies! We're laser focused on bringing new treatments to patients faster and more efficiently by building a tech and AI driven pharma company, and we're hiring across many teams. Join us! See our open roles: https://lnkd.in/eVsCezpp Read more here: https://lnkd.in/ejtXNpUQ #biopharma #biotech #pharma #drugdevelopment #ai #innovation
-
Looking forward to having Gavin Corcoran, MD FACP join this panel about AI in Drug Development happening next week at #FierceBiotechSummit together with Karim Budhwani, Mark Brenckle, Michelle Chen, and Jeffrey Reid. We hope to see you there! You can find sign-up details below. Fierce Pharma Fierce Life Sciences Events CerFlux Alkermes Insilico Medicine Regeneron #drugdevelopment #pharma #biotech #ai #clinicaltrials #clinicaldevelopment #genai
Join us at the #FierceBiotechSummit for this featured session on September 30-Oct 1, 2024 ❗REGISTER NOW! Save up to $300 with the Advanced Rate: https://ow.ly/lXMK50SWXUY 💡What to Expect: In the session "Decoding AI in Drug Development", you'll explore how artificial intelligence is revolutionizing the drug development process. Experts will discuss the latest AI applications in identifying drug targets, optimizing clinical trials, and predicting outcomes. Attendees can expect to gain valuable insights into how AI is driving efficiency, innovation, and precision in biotech, transforming the way new therapies are developed and brought to market. A big thank you to our moderator and speakers: - Karim Budhwani from CerFlux - Mark Brenckle from Alkermes - Gavin Corcoran, MD FACP from Formation Bio - Michelle Chen from Insilico Medicine - Jeffrey Reid from Regeneron Stay Updated by following Fierce Life Sciences Events #FierceBiotech #Biotech #FiercePharma #Pharma #Innovation
-
Check out Formation Bio's Sandeep Basnet, MD and Chris Knight on the Joint Action podcast with David Hunter, discussing disease-modifying osteoarthritis drugs and the great opportunity to leverage AI technologies to help advance clinical development. https://lnkd.in/ejJURanq
-
Coming up next week on September 17th! Melanie Hullings will be presenting at R in Pharma's GenAI Day which will focus on examples of using generative artificial intelligence with an emphasis in the drug development space and clinical domain. The event is free and taking place on Zoom. Learn more and sign up at https://lnkd.in/erZCZsqw.
-
Delighted to share a recently published paper co-authored by Formation Bio team members Luping Zhao, Chris Knight, and Ken Somberg exploring the question: Is it more effective to detect the effects of disease-modifying osteoarthritis treatment on cartilage using MRI scans if researchers know the order of the images? OARSI - Osteoarthritis Research Society International #drugdevelopment #pharma #clinicaldevelopment #DMOAD https://lnkd.in/ddvKMp7K
Is detection of disease-modifying osteoarthritis drug treatment more effective when performing cartilage morphometry without blinding to MR image acquisition order?
oarsijournal.com
-
Formation Bio's Melanie Hullings and Laura Fazio, MS will be presenting at PHUSE on July 25th in Pennsylvania. We hope to see you there! -- In the era of AI and advanced analytics propelling data management forward at an exponential rate, partnership between Clinical Data Managers and Clinical Data Scientists is critical. Laura and Mel will discuss how these teams at Formation Bio work together to create fit-for-purpose tools to automate data cleaning, reporting and analytics. They will also share perspectives on where AI-driven solutions will fit into the clinical data ecosystem and solicit feedback on the gaps that still need filling to support real-time data-driven decisions. More confernece details here: https://rb.gy/r2yctv #datascience #biotech #pharma #drugdevelopment #clinicaltrials #clinicaldatamanagement
-
Formation Bio reposted this
Thrilled to be partnering with the Formation Bio team on their Series D fundraise. Formation Bio is building a tech and AI-native pharma company that is radically changing the way drug development is done and making it much more efficient. Benjamine Liu has built a team that brings together the best across pharma, AI, and technology to tackle one of the world’s most challenging problems and bring new treatments to patients faster. I and the full SV Angel team are incredibly excited to be a part of the journey!
Today we announced our $372MM Series D financing, led by Andreessen Horowitz with major participation from Sanofi. Existing investors also joined this round, including Sequoia Capital, Thrive Capital, Lachy Groom, and Emerson Collective, along with new investors SV Angel Growth and FPV Ventures and others. At Formation Bio, we are building the pharma company of the future, where human expertise and AI collaborate seamlessly to make drug development and clinical trials dramatically more efficient. As AI accelerates drug discovery, generating more promising candidate drugs than ever before, we believe the most consequential bottleneck to bringing more medicines to patients is the staggering cost and time needed for drug development and clinical trials. By designing and developing AI specifically tailored for drug development, we can increase the total number of candidate drugs that can progress through development, and ultimately deliver more new treatments to patients faster and more efficiently. We are proud to partner with best-in-class investors and advisors from both pharma and tech backgrounds along the way. Read more here: https://lnkd.in/et6uKzGV #pharma #biotech #funding #fundraise #tech #ai #drugdevelopment
-
Formation Bio reposted this
Proud to see Formation Bio continue its incredible journey with a $372M Series D. Their AI-driven approach is transforming drug development!
Today we announced our $372MM Series D financing, led by Andreessen Horowitz with major participation from Sanofi. Existing investors also joined this round, including Sequoia Capital, Thrive Capital, Lachy Groom, and Emerson Collective, along with new investors SV Angel Growth and FPV Ventures and others. At Formation Bio, we are building the pharma company of the future, where human expertise and AI collaborate seamlessly to make drug development and clinical trials dramatically more efficient. As AI accelerates drug discovery, generating more promising candidate drugs than ever before, we believe the most consequential bottleneck to bringing more medicines to patients is the staggering cost and time needed for drug development and clinical trials. By designing and developing AI specifically tailored for drug development, we can increase the total number of candidate drugs that can progress through development, and ultimately deliver more new treatments to patients faster and more efficiently. We are proud to partner with best-in-class investors and advisors from both pharma and tech backgrounds along the way. Read more here: https://lnkd.in/et6uKzGV #pharma #biotech #funding #fundraise #tech #ai #drugdevelopment
-
Formation Bio reposted this
Today we announced our $372MM Series D financing, led by Andreessen Horowitz with major participation from Sanofi. Existing investors also joined this round, including Sequoia Capital, Thrive Capital, Lachy Groom, and Emerson Collective, along with new investors SV Angel Growth and FPV Ventures and others. At Formation Bio, we are building the pharma company of the future, where human expertise and AI collaborate seamlessly to make drug development and clinical trials dramatically more efficient. As AI accelerates drug discovery, generating more promising candidate drugs than ever before, we believe the most consequential bottleneck to bringing more medicines to patients is the staggering cost and time needed for drug development and clinical trials. By designing and developing AI specifically tailored for drug development, we can increase the total number of candidate drugs that can progress through development, and ultimately deliver more new treatments to patients faster and more efficiently. We are proud to partner with best-in-class investors and advisors from both pharma and tech backgrounds along the way. Read more here: https://lnkd.in/et6uKzGV #pharma #biotech #funding #fundraise #tech #ai #drugdevelopment